188 related articles for article (PubMed ID: 6228500)
1. Ticlopidine activity on platelet function in patients with enhanced platelet aggregation. A short-term crossover study.
Gensini GF; Favilla S; Breschi C; Abbate R; Costanzo G; Neri Serneri GG
Haemostasis; 1983; 13(5):294-300. PubMed ID: 6228500
[TBL] [Abstract][Full Text] [Related]
2. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2.
Vincent JE; Zijlstra FJ; de Wit CM; Bonta IL
Prostaglandins Leukot Med; 1984 Dec; 16(3):279-83. PubMed ID: 6396655
[TBL] [Abstract][Full Text] [Related]
3. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
Lagarde M; Ghazi I; Dechavanne M
Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet aggregation by a new agent, Ticlopidine.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
[TBL] [Abstract][Full Text] [Related]
5. Effects of ticlopidine of platelet function in men with stable angina pectoris.
Berglund U; von Schenck H; Wallentin L
Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet function by ticlopidine in arteriosclerosis obliterans of the lower limbs.
Davì G; Pinto A; Francavilla G; Paterna S; Campisi D; Strano A
Thromb Res; 1985 Oct; 40(2):275-81. PubMed ID: 2933846
[No Abstract] [Full Text] [Related]
7. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat.
Randon J; Lefort J; Vargaftig BB
Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623
[TBL] [Abstract][Full Text] [Related]
8. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
9. The effect of ticlopidine on the aggregation of rat blood platelets and on the formation of metabolites from arachidonic acid and 8,11,14-eicosatrienoic acid in rat platelets during aggregation, and in the rat kidney.
Vincent JE; Zijlstra FJ; vd Veerdonk MA; Bonta IL
Agents Actions; 1982 Jul; 12(3):377-81. PubMed ID: 6814210
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandins and platelet aggregation.
Smith JB
Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral ticlopidine on arachidonic acid products in human platelets.
Bruno JJ; Chang LF; McSpadden MM; Yang D
Agents Actions Suppl; 1984; 15():76-87. PubMed ID: 6435408
[No Abstract] [Full Text] [Related]
12. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives.
Pan IQ; Hall ER; Wu KK
Br J Haematol; 1984 Oct; 58(2):317-23. PubMed ID: 6089860
[TBL] [Abstract][Full Text] [Related]
13. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
14. Ticlopidine in China: comparative study on the effect of two dose levels on bleeding time and platelet function in healthy volunteers.
Ruan C; Destelle G; Wang Z; Wan H; He Y; Cheng D; Li P; Duffas M
Haemostasis; 1989; 19(2):94-9. PubMed ID: 2731781
[TBL] [Abstract][Full Text] [Related]
15. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.
Sugidachi A; Asai F; Ogawa T; Inoue T; Koike H
Br J Pharmacol; 2000 Apr; 129(7):1439-46. PubMed ID: 10742300
[TBL] [Abstract][Full Text] [Related]
16. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase.
Jeng JH; Chen SY; Liao CH; Tung YY; Lin BR; Hahn LJ; Chang MC
Free Radic Biol Med; 2002 May; 32(9):860-71. PubMed ID: 11978487
[TBL] [Abstract][Full Text] [Related]
17. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
18. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia.
Uchiyama S; Sone R; Nagayama T; Shibagaki Y; Kobayashi I; Maruyama S; Kusakabe K
Stroke; 1989 Dec; 20(12):1643-7. PubMed ID: 2531943
[TBL] [Abstract][Full Text] [Related]
20. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
